From Discovery to Development: The Role of RUO Antibodies in Biologics Process Development

 Why RUO Antibodies Matter in Process Development

Process development is the bridge between early discovery and clinical manufacturing. At this critical stage, teams must characterize molecules, monitor quality, and establish reproducible assays that will scale into regulated environments. Reliable antibodies are central to this work.

ProSci’s Research Use Only (RUO) antibodies, available through both our extensive catalog and custom antibody development services, empower process development teams with precision tools to evaluate biologics. With more than 27 years of expertise, we provide antibodies designed to meet the unique demands of critical quality attributes (CQAs), CMC batch release, PK assays, potency testing, and advanced biologics analytics.

RUO Antibodies Across Process Development Workflows

Critical Quality Attributes (CQA) & CMC Batch Release

Challenge: Ensuring lot-to-lot consistency and regulatory readiness.

Solution: RUO antibodies detect product- and process-related impurities including host cell proteins (HCPs), glycosylation variants, and aggregation markers.

Impact: Supports comparability studies and reliable CMC batch release decisions.

https://www.prosci-inc.com/blog/from-discovery-to-development-the-role-of-ruo-antibodies-in-biologics-process-development/

Comments

Post a Comment

Popular posts from this blog

ProSci Antibodies Power Breakthrough Brain Mapping Technology

  How custom antibody development enabled next-generation neuron tracing in a landmark study from Harvard How custom antibody development enabled next-generation neuron tracing in a landmark study from Harvard and MIT Introduction When the world’s leading neuroscience teams set out to map the brain with nanoscale precision, they faced a simple but critical obstacle: no existing antibodies could do the job. So they turned to ProSci. In a groundbreaking preprint on  bioRxiv — “Combinatorial protein barcodes enable self-correcting neuron tracing with nanoscale molecular context” —researchers from the Church and Boyden labs unveiled PRISM, a new platform that combines protein barcodes, tissue expansion, and iterative immunostaining to reconstruct neurons with extraordinary accuracy. To make it possible, they needed custom antibodies that didn’t yet exist. ProSci created them. Enabling Discovery When No Antibody Exists The PRISM method uses engineered “barcod...
Read more